- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02818881
Electromyography and Yoga
August 31, 2017 updated by: Joseph Signorile, University of Miami
Differences in Energy Expenditure of Two Commonly Used Yoga Protocols
This study examined the muscle activity, movement patterns, and oxygen consumption during a series of yoga poses with slow and rapid transitions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Coral Gables, Florida, United States, 33146
- Max Orovitz Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have at least 1 year of yoga experience;
- Practice a minimum of twice per week (app 2 hours or more);
- Demonstrate good form in the poses (asanas) making up the Sun A and Sun B sequences;
Exclusion Criteria:
- If they have any uncontrolled neuromuscular, orthopedic or cardiovascular disease;
- If they have been advised by their physicians that they should not exercise;
- If they cannot complete three cycles each of the Sun A and B sequence in good form.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High-speed then low-speed yoga
Subjects received a single session of High-speed yoga and within one week a single session of Low-speed yoga
|
|
|
Experimental: Low-speed then high-speed yoga
Subjects received a single session of Low-speed yoga and within one week a single session of High-speed yoga
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of energy expenditures for high-speed and low-speed yoga
Time Frame: Day 3
|
We measured calories for all subjects across both conditions
|
Day 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of muscle activities for high-speed and low-speed yoga
Time Frame: Day 3
|
We measured muscle activities for all subjects across both conditions
|
Day 3
|
|
Comparison of oxygen utilization for high-speed and low-speed yoga
Time Frame: Day 2
|
We measured oxygen consumption for all subjects across both conditions
|
Day 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
June 23, 2016
First Submitted That Met QC Criteria
June 27, 2016
First Posted (Estimate)
June 30, 2016
Study Record Updates
Last Update Posted (Actual)
September 5, 2017
Last Update Submitted That Met QC Criteria
August 31, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Dopamine Agents
- Dopamine Uptake Inhibitors
- Central Nervous System Stimulants
- Sympathomimetics
- Adrenergic Uptake Inhibitors
- Methamphetamine
Other Study ID Numbers
- 20140550
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.